SenesTech to Attend Lytham Partners Fall 2025 Investor Conference on September 30, 2025
Company Participation: SenesTech, Inc. will participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025, with a webcast presentation at 2:45 p.m. ET and virtual one-on-one meetings with investors.
Company Mission: SenesTech focuses on humane pest management through fertility control, aiming to create healthier environments with products like Evolve rodent birth control, which enhances pest management effectiveness while reducing reliance on traditional poisons.
Trade with 70% Backtested Accuracy
Analyst Views on SNES
No data
About SNES
About the author
SenesTech Expands International Reach with the Addition of the Belize Raptor Center as an Official Distributor of Evolve® Rat Birth Control
Introduction of Evolve® Rat Birth Control: SenesTech, Inc. has partnered with Sarah Mann and the Belize Raptor Center to introduce Evolve® Rat Birth Control in Belize, aiming to manage rodent populations humanely and sustainably amidst rising concerns over toxic rodenticides.
Ecological Impact and Education Campaign: The initiative addresses the ecological threats posed by unregulated rodenticides, launching a grassroots education campaign to inform the public about the dangers of these poisons and promote fertility control as a safer alternative.
SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA
Financial Performance: SenesTech reported a 43% increase in revenues for Q3 2025, reaching $690,000, with Evolve® Rodent Birth Control™ products driving a 77% year-over-year growth, now accounting for 85% of total revenue.
Operational Highlights: The company saw significant growth in various channels, including a 139% increase in municipal revenue and a 254% rise in retail revenue, supported by expanded partnerships and e-commerce sales.
Profitability Progress: Despite a net loss of $1.3 million, the adjusted EBITDA loss improved to $1.2 million, indicating progress towards profitability, bolstered by a strong cash balance of $10.2 million.
Strategic Outlook: CEO Joel Fruendt emphasized the company's commitment to pursuing profitable growth and expanding its innovative pest control product line, aiming for breakeven and long-term market potential.
